HER2 testing in gastric cancer - results of a German expert meeting

被引：2

作者：

Lordick, F. ^{[1
]}

Al-Batran, S. E. ^{[2
]}

Hofheinz, R. D. ^{[3
]}

Lorenzen, S. ^{[4
]}

Thuss-Patience, P. ^{[5
]}

Baretton, G. B. ^{[6
]}

Dietel, M. ^{[7
]}

Gaiser, T. ^{[8
]}

Kirchner, T. ^{[9
]}

Kreipe, H. H. ^{[10
]}

Quaas, A. ^{[11
]}

Roecken, C. ^{[12
]}

Rueschoff, J. ^{[13
]}

Tannapfel, A. ^{[14
]}

机构：

[1] Univ Klinikum Leipzig, Univ Krebszentrum UCCL, Liebigstr 7, D-04103 Leipzig, Germany

[2] Krankenhaus NW Frankfurt, Frankfurt, Germany

[3] Univ Med Mannheim, Mannheim, Germany

[4] Klinikums Rechts Isar, Med Klin 3, Munich, Germany

[5] Charite, CVK, Charite Ctr Tumormed CC14, Berlin, Germany

[6] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Inst Pathol, Dresden, Germany

[7] Charite, Inst Pathol, Campus Mitte, Berlin, Germany

[8] Pathol Inst Mannheim, Mannheim, Germany

[9] Univ Munich, Inst Pathol, Munich, Germany

[10] Hannover Med Sch, Inst Pathol, Hannover, Germany

[11] Uniklin Koln, Inst Pathol, Cologne, Germany

[12] Univ Kiel, Inst Pathol, Kiel, Germany

[13] Targos GmbH, Inst Pathol Nordhessen, Kassel, Germany

[14] Ruhr Univ Bochum, Inst Pathol, Georgius Agr Stiftung Ruhr, Berufsgenossenschaftlichen Univ Klinikum, Bochum, Germany

来源：

ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2016年 / 54卷 / 08期

关键词：

gastric cancer; HER2; testing; consensus; quality assurance; trastuzumab; PROGNOSTIC-FACTOR; AMPLIFICATION; ASSOCIATION; CARCINOMA;

D O I：

10.1055/s-0042-110794

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Valid HER2 testing is essential for optimal therapy of patients with HER2 positive gastric cancer and the correct use of first-line treatment. While each breast cancer is routinely being tested for the HER2 status, HER2 testing in gastric cancer has still not become part of the routine and is often only done upon request by the therapist. An interdisciplinary German expert group took the challenges of HER2 testing in gastric cancer as an opportunity to address essential aspects and questions for the practical use of HER2 testing in this indication from the perspective of pathologists and therapists. The recommendations made in this manuscript reflect the consensus of all participants and correspond to their opinions and long-term experience.

引用

页码：791 / 796

页数：6

共 50 条

[21] HER2 Testing in Gastric and Gastroesophageal Adenocarcinomas
Vakiani, Efsevia
ADVANCES IN ANATOMIC PATHOLOGY, 2015, 22 (03) : 194 - 201
[22] Treatment of HER2 Positive Advanced Gastric Cancer: Deviations in HER2 Results and Its Impact on Survival
Haffner, Ivonne
Schierle, Katrin
Maier, Dieter
Geier, Birgitta
Raimundez, Elba
Hasenauer, Jan
Luber, Birgit
Kretzschmar, Albrecht
von Weikersthal, Ludwig Fischer
Ahlborn, Miriam
Riera, Jorge
Rau, Beate
Siegler, Gabriele
Fuxius, Stefan
Decker, Thomas
Wittekind, Christian
Lordick, Florian
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 65 - 65
[23] Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing
Chung, H.
Bang, Y. J.
Xu, J. M.
Lordick, F.
Sawaki, A.
Lipatov, O.
Lehle, M.
Pickl, M.
Rueschoff, J.
Van Cutsem, E.
EJC SUPPLEMENTS, 2009, 7 (02): : 364 - 364
[24] HER2 in focus—gastric cancer
Aysegül Ilhan-Mutlu
memo - Magazine of European Medical Oncology, 2023, 16 : 217 - 217
[25] SERUM HER2 IN GASTRIC CANCER
Saito, M.
Kaneto, H.
Okuda, H.
Kodaira, J.
Hagiwara, T.
Kozawa, H.
Yoshimoto, M.
Yamashita, K.
Arimura, Y.
Shinomura, Y.
ANNALS OF ONCOLOGY, 2013, 24 : 33 - 33
[26] Testing for HER2 in breast cancer
Lewis, F
Jackson, P
Lane, S
Coast, G
Hanby, AM
HISTOPATHOLOGY, 2004, 45 (03) : 207 - 217
[27] Significance of accurate HER2 testing as a new biomarker in advanced gastric cancer
Kusumoto, Tetsuya
Ohtsu, Hajime
Kawano, Hiroyuki
Ando, Koji
Ida, Satoshi
Kimura, Yasuo
Saeki, Hiroshi
Oki, Eiji
Morita, Masaru
Maehara, Yoshihiko
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
[28] Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
Warneke, V. S.
Behrens, H. -M.
Boeger, C.
Becker, T.
Lordick, F.
Ebert, M. P. A.
Roecken, C.
ANNALS OF ONCOLOGY, 2013, 24 (03) : 725 - 733
[29] HER2/neu Testing in Gastric Cancer by Immunohistochemistry Assessment of Interlaboratory Variation
Sheffield, Brandon S.
Garratt, John
Kalloger, Steve E.
Li-Chang, Hector H.
Torlakovic, Emina E.
Gilks, C. Blake
Schaeffer, David F.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (11) : 1495 - 1502
[30] Gastric HER2 Testing Study (GaTHER): An Evaluation of Gastric/Gastroesophageal Junction Cancer Testing Accuracy in Australia
Fox, Stephen B.
Kumarasinghe, Marian Priyanthi
Armes, Jane E.
Bilous, Michael
Cummings, Margaret C.
Farshid, Gelareh
Fitzpatrick, Nicole
Francis, Glenn D.
McCloud, Philip I.
Raymond, Wendy
Morey, Adrienne
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (04) : 577 - 582

← 1 2 3 4 5 →